Morphine and HIV-Tat increase microglial-free radical production and oxidative stress: Possible role in cytokine regulation

Journal of Neurochemistry

Volumn 108, Issue 1, 2009, Pages 202-215

  Turchan Cholewo, Jadwiga ^a   Dimayuga, Filomena O ^a   Gupta, Sunita ^b   Keller, Jeffrey N ^b   Knapp, Pamela E ^c   Hauser, Kurt F ^c   Bruce Keller, Annadora J ^b  

^a UNIVERSITY OF KENTUCKY   (United States)

^b PENNINGTON BIOMEDICAL RESEARCH CENTER   (United States)

^c VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

Author keywords

Cytokines; Inflammation; Opiates; Proteasome; Redox signaling

Indexed keywords

FREE RADICAL; INTERLEUKIN 6; MONOCYTE CHEMOTACTIC PROTEIN 1; MORPHINE; PROTEASOME; REACTIVE OXYGEN METABOLITE; TRANSACTIVATOR PROTEIN; TUMOR NECROSIS FACTOR ALPHA; VIRUS PROTEIN;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; CYTOKINE RELEASE; CYTOTOXICITY; HUMAN IMMUNODEFICIENCY VIRUS; MICROGLIA; MOUSE; NONHUMAN; OXIDATION; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN INTERACTION;

ANALGESICS, OPIOID; ANALYSIS OF VARIANCE; ANIMALS; ANIMALS, NEWBORN; APOPTOSIS REGULATORY PROTEINS; BRAIN; CELL SURVIVAL; CELLS, CULTURED; CYTOKINES; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME-LINKED IMMUNOSORBENT ASSAY; LEUPEPTINS; MICE; MICROGLIA; MORPHINE; OXIDATIVE STRESS; PROTEASE INHIBITORS; PROTEASOME ENDOPEPTIDASE COMPLEX; RATS; RATS, SPRAGUE-DAWLEY; REACTIVE OXYGEN SPECIES; RECOMBINANT FUSION PROTEINS; TAT GENE PRODUCTS, HUMAN IMMUNODEFICIENCY VIRUS;

HUMAN IMMUNODEFICIENCY VIRUS;

EID: 57249086430     PISSN: 00223042     EISSN: 14714159     Source Type: Journal    
DOI: 10.1111/j.1471-4159.2008.05756.x     Document Type: Article

References (110)

1. Aloisi F. (2001) Immune function of microglia. Glia 36, 165 179.
2. Anthony I. C., Ramage S. N., Carnie F. W., Simmonds P. Bell J. E. (2005a) Does drug abuse alter microglial phenotype and cell turnover in the context of advancing HIV infection? Neuropathol. Appl. Neurobiol. 31, 325 338.
3. Anthony I. C., Ramage S. N., Carnie F. W., Simmonds P. Bell J. E. (2005b) Influence of HAART on HIV-related CNS disease and neuroinflammation. J. Neuropathol. Exp. Neurol. 64, 529 536.
4. Apcher G. S., Heink S., Zantopf D., Kloetzel P. M., Schmid H. P., Mayer R. J. Krüger E. (2003) Human immunodeficiency virus-1 Tat protein interacts with distinct proteasomal alpha and beta subunits. FEBS Lett. 553, 200 204.
5. Badie B., Schartner J., Vorpahl J. Preston K. (2000) Interferon-gamma induces apoptosis and augments the expression of Fas and Fas ligand by microglia in vitro. Exp. Neurol. 162, 290 296.
6. Barger S. W. Basile A. S. (2001) Activation of microglia by secreted amyloid precursor protein evokes release of glutamate by cystine exchange and attenuates synaptic function. J. Neurochem. 76, 846 854.
7. Barger S. W., Goodwin M. E., Porter M. M. Beggs M. L. (2007) Glutamate release from activated microglia requires the oxidative burst and lipid peroxidation. J. Neurochem. 101, 1205 1213.
8. Barr M. C., Huitron-Resendiz S., Sanchez-Alavez M., Henriksen S. J. Phillips T. R. (2003) Escalating morphine exposures followed by withdrawal in feline immunodeficiency virus-infected cats: a model for HIV infection in chronic opiate abusers. Drug Alcohol Depend. 72, 141 149.
9. Bell J. E., Donaldson Y. K., Lowrie S., McKenzie C. A., Elton R. A., Chiswick A., Brettle R. P., Ironside J. W. Simmonds P. (1996) Influence of risk group and zidovudine therapy on the development of HIV encephalitis and cognitive impairment in AIDS patients. AIDS 10, 493 499.
10. Bell J. E., Arango J. C., Robertson R., Brettle R. P., Leen C. Simmonds P. (2002) HIV and drug misuse in the Edinburgh cohort. J. Acquir. Immune Defic. Syndr. 31 (Suppl. 2 S35 S42.
11. Bhaskaran M., Reddy K., Sharma S., Singh J., Radhakrishnan N., Kapasi A. Singhal P. C. (2001) Morphine-induced degradation of the host defense barrier: role of macrophage injury. J. Infect. Dis. 184, 1524 1531.
12. Bhat R. S., Bhaskaran M., Mongia A., Hitosugi N. Singhal P. C. (2004) Morphine-induced macrophage apoptosis: oxidative stress and strategies for modulation. J. Leukoc. Biol. 75, 1131 1138.
13. Borissenko L. Groll M. (2007) Diversity of proteasomal missions: fine tuning of the immune response. Biol. Chem. 388, 947 955.
14. Bruce-Keller A. J., Geddes J. W., Knapp P. E., McFall R. W., Keller J. N., Holtsberg F. W., Steiner S. M., Partharasy S. Mattson M. P. (1999) Anti-death properties of TNF against metabolic poisoning: mitochondrial stabilization by MnSOD. J. Neuroimmunol. 93, 53 71.
15. Bruce-Keller A. J., Barger S. W., Moss N. I., Pham J. T., Keller J. N. Nath A. (2001) Pro-inflammatory and pro-oxidant properties of the HIV protein Tat in a microglial cell line: attenuation by 17beta-estradiol. J. Neurochem. 78, 1315 1324.
16. Chao C. C., Gekker G., Sheng W. S., Hu S., Tsang M. Peterson P. K. (1994) Priming effect of morphine on the production of tumor necrosis factor-alpha by microglia: implications in respiratory burst activity and human immunodeficiency virus-1 expression. J. Pharmacol. Exp. Ther. 269, 198 203.
17. Chao C. C., Hu S. Peterson P. K. (1996) Opiates, glia, and neurotoxicity. Adv. Exp. Med. Biol. 402, 29 33.
18. Chao C. C., Hu S., Shark K. B., Sheng W. S., Gekker G. Peterson P. K. (1997) Activation of mu opioid receptors inhibits microglial cell chemotaxis. J. Pharmacol. Exp. Ther. 281, 998 1004.
19. Chen P., Mayne M., Power C. Nath A. (1997) The Tat protein of HIV-1 induces tumor necrosis factor-alpha production. J. Biol. Chem. 272, 22385 22388.
20. D'Aversa T. G., Eugenin E. A. Berman J. W. (2005) NeuroAIDS: contributions of the human immunodeficiency virus-1 proteins Tat and gp120 as well as CD40 to microglial activation. J. Neurosci. Res. 81, 436 446.
21. Davies J., Everall I. P., Weich S., McLaughlin J., Scaravilli F. Lantos P. (1997) HIV-associated brain pathology in the United Kingdom: an epidemiological study. AIDS 11, 1145 1150.
22. Ding Q. Keller J. N. (2001) Proteasome inhibition in oxidative stress neurotoxicity: implications for heat shock proteins. J. Neurochem. 77, 1010 1017.
23. Ding Q., Lewis J. J., Strum K. M., Dimayuga E., Bruce-Keller A. J., Dunn J. C. Keller J. N. (2002) Polyglutamine expansion, protein aggregation, proteasome activity, and neural survival. J. Biol. Chem. 277, 13935 13942.
24. Ding Q., Reinacker K., Dimayuga E. et al. (2003) Role of the proteasome in protein oxidation and neural viability following low-level oxidative stress. FEBS Lett. 546, 228 232.
25. Ding Q., Dimayuga E., Markesbery W. R. Keller J. N. (2006) Proteasome inhibition induces reversible impairments in protein synthesis. FASEB J. 20, 1055 1063.
26. Donahoe R. M. (2001) Multiple ways that drug abuse might influence AIDS progression: clues from a monkey model. J. Neuroimmunol. 147, 28 32.
27. Donahoe R. M. Vlahov D. (1998) Opiates as potential cofactors in progression of HIV-1 infections to AIDS. J. Neuroimmunol. 83, 77 87.
28. Droge W. (2002) Free radicals in the physiological control of cell function. Physiol. Rev. 82, 47 95.
29. 2+, and the release of MCP-1, RANTES, and IL-6 by astrocytes treated with opiates and HIV-1 Tat. Glia 50, 91 106.
30. El-Hage N., Wu G., Ambati J., Bruce-Keller A. J., Knapp P. E. Hauser K. F. (2006) CCR2 mediates increases in glial activation caused by exposure to HIV-1 Tat and opiates. J. Neuroimmunol. 178, 9 16.
31. Everall I. P. (2004) Interaction between HIV and intravenous heroin abuse? J. Neuroimmunol. 147, 13 15.
32. Fine S. M., Maggirwar S. B., Elliott P. R., Epstein L. G., Gelbard H. A. Dewhurst S. (1999) Proteasome blockers inhibit TNF-alpha release by lipopolysaccharide stimulated macrophages and microglia: implications for HIV-1 dementia. J. Neuroimmunol. 95, 55 64.
33. Fu X., Richards D. E., Ait-Ali T., Hynes L. W., Ougham H., Peng J. Harberd N. P. (2002) Gibberellin-mediated proteasome-dependent degradation of the barley DELLA protein SLN1 repressor. Plant Cell 14, 3191 3200.
34. Gao H. M., Liu B., Zhang W. Hong J. S. (2003) Critical role of microglial NADPH oxidase-derived free radicals in the in vitro MPTP model of Parkinson's disease. FASEB J. 13, 1954 1956.
35. Gavioli R., Gallerani E., Fortini C. et al. (2004) HIV-1 tat protein modulates the generation of cytotoxic T cell epitopes by modifying proteasome composition and enzymatic activity. J. Immunol. 173, 3838 3843.
36. Glass J., Fedor H., Wesselingh S. L. McArthur J. C. (1995) Immunocytochemical quantification of human immunodeficiency virus in the brain; correlation with dementia. Ann. Neurol. 38, 755 762.
37. Goldberg A., Cascio P., Saric T. Rock K. (2002) The importance of the proteasome and subsequent proteolytic steps in the generation of antigenic peptides. Mol. Immunol. 39, 147 164.
38. Grant I., Sacktor H. McArthur J. (2005). HIV neurocognitive disorders. in The Neurology of AIDS (Gendelman H. E., Grant I., Everall I., Lipton S. A. Swindells S., eds), pp. 357 373. Oxford University Press, London.
39. Gray F., Adle-Biassette H., Chretien F., Lorin de la Grandmaison G., Force G. Keohane C. (2001) Neuropathology and neurodegeneration in human immunodeficiency virus infection. Pathogenesis of HIV-induced lesions of the brain, correlations with HIV-associated disorders and modifications according to treatments. Clin. Neuropathol. 20, 146 155.
40. Grune T., Reinheckel T. Davies K. (1996) Degradation of oxidized proteins in K562 human hematopoietic cells by proteasome. J. Biol. Chem. 271, 15504 15509.
41. Halliwell B. Whiteman M. (2004) Measuring reactive species and oxidative damage in vivo and in cell culture: how should you do it and what do the results mean? Br. J. Pharmacol. 142, 231 255.
42. Hayashi T. Faustman D. (2000) A role for NF-kappaB and the proteasome in autoimmunity. Arch. Immunol. Ther. Exp. (Warsz.) 48, 353 365.
43. Hu S., Peterson P. K. Chao C. C. (1998) Kappa-opioid modulation of human microglial cell superoxide anion generation. Biochem. Pharmacol. 56, 285 288.
44. Huang X., Seifert U., Salzmann U., Henklein P., Preissner R., Henke W., Sijts A. J., Kloetzel P. M. Dubiel W. (2002) The RTP site shared by the HIV-1 Tat protein and the 11S regulator subunit alpha is crucial for their effects on proteasome function including antigen processing. J. Mol. Biol. 323, 771 782.
45. Jana A. Pahan K. (2004) Fibrillar amyloid-beta peptides kill human primary neurons via NADPH oxidase-mediated activation of neutral sphingomyelinase. Implications for Alzheimer's disease. J. Biol. Chem. 279, 51451 51459.
46. Kalogeris T., Gray L., Laroux F. S., Cockrell A., Fuseler J., Conner E. M., Brand S. Grisham M. B. (1999) Selective proteasome inhibitors as anti-inflammatory agents. Expert Opin. Investig. Drugs. 8, 1397 1407.
47. Kapadia F., Vlahov D., Donahoe R. M. Friedland G. (2005) The role of substance abuse in HIV disease progression: reconciling differences from laboratory and epidemiologic investigations. Clin. Infect. Dis. 41, 1027 1034.
48. Kaul N. Forman H. J. (1996) Activation of NF kappa B by the respiratory burst of macrophages. Free Radic. Biol. Med. 21, 401 405.
49. Keenan J. I., Peterson R. A. II. Hampton M. B. (2005) NADPH oxidase involvement in the pathology of Helicobacter pylori infection. Free Radic. Biol. Med. 38, 1188 1196.
50. Keller J. N., Kindy M. S., Holtsberg F. W. et al. (1998) Mitochondrial MnSOD prevents neuroal apoptosis and reduces ischemic brian injury: supression of peroxynitrite production, lipid peroxidation, and mitochondrial dysfunction. J. Neurosci. 18, 687 697.
51. Keller J. N., Gee J. Ding Q. (2002) The proteasome in brain aging. Ageing Res. Rev. 2, 279 293.
52. Keller J. N., Schmitt F. A., Scheff S. W., Ding Q., Chen Q., Butterfield D. A. Markesbery W. R. (2005) Evidence of increased oxidative damage in subjects with mild cognitive impairment. Neurology 64, 1152 1156.
53. Komatsu J., Koyama H., Maeda N. Aratani Y. (2006) Earlier onset of neutrophil-mediated inflammation in the ultraviolet-exposed skin of mice deficient in myeloperoxidase and NADPH oxidase. Inflamm. Res. 55, 200 206.
54. Kumar R., Orsoni S., Norman L. et al. (2006) Chronic morphine exposure causes pronounced virus replication in cerebral compartment and accelerated onset of AIDS in SIV/SHIV-infected Indian rhesus macaques. Virology 354, 192 206.
55. Laakko T., King L. Fraker P. (2002) Versatility of merocyanine 540 for the flow cytometric detection of apoptosis in human and murine cells. J. Immunol. Methods 261, 129 139.
56. Li Q. Engelhardt J. F. (2006) Interleukin-1beta induction of NFkappaB is partially regulated by H2O2-mediated activation of NFkappaB-inducing kinase. J. Biol. Chem. 281, 1495 1505.
57. Ling E. A., Ng Y. K., Wu C. H. Kaur C. (2001) Microglia: its development and role as a neuropathology sensor. Prog. Brain Res. 132, 61 79.
58. Liu Y., Qin L., Wilson B. C., An L., Hong J. S. Liu B. (2002) Inhibition by naloxone stereoisomers of beta-amyloid peptide (1-42)-induced superoxide production in microglia and degeneration of cortical and mesencephalic neurons. J. Pharmacol. Exp. Ther. 302, 1212 1219.
59. Lolait S. J., Clements J. A., Markwick A. J., Cheng C., McNally M., Smith A. I. Funder J. W. (1986) Pro-opiomelanocortin messenger ribonucleic acid and posttranslational processing of beta endorphin in spleen macrophages. J. Clin. Invest. 77, 1776 1779.
60. Lucas G. M., Griswold M., Gebo K. A., Keruly J., Chaisson R. E. Moore R. D. (2006) Illicit drug use and HIV-1 disease progression: a longitudinal study in the era of highly active antiretroviral therapy. Am. J. Epidemiol. 163, 412 420.
61. MacFarlane A. S., Peng X., Meissler J. J. J., Rogers T. J., Geller E. B., Adler M. W. Eisenstein T. K. (2000) Morphine increases susceptibility to oral Salmonella typhimurium infection. J. Infect. Dis. 181, 1350 1358.
62. Machelska H. Stein C. (2006) Leukocyte-derived opioid peptides and inhibition of pain. J. Neuroimmunol. Pharmacol. 1, 90 97.
63. Mahajan S. D., Aalinkeel R., Reynolds J. L., Nair B. B., Fernandez S. F., Schwartz S. A. Nair M. P. (2005) Morphine exacerbates HIV-1 viral protein gp120 induced modulation of chemokine gene expression in U373 astrocytoma cells. Curr. HIV Res. 3, 277 288.
64. Marikovsky M., Ziv V., Nevo N., Harris-Cerruti C. Mahler O. (2003) Cu/Zn superoxide dismutase plays important role in immune response. J. Immunol. 170, 2993 3001.
65. McArthur J. C., Brew B. J. Nath A. (2005) Neurological complications of HIV infection. Lancet Neurol. 4, 543 555.
66. McCarthy L., Wetzel M., Sliker J. K., Eisenstein T. K. Rogers T. J. (2001) Opioids, opioid receptors, and the immune response. Drug Alcohol Depend. 62, 111 123.
67. Mehlhase J., Gieche J., Ullrich O., Sitte N. Grune T. (2000) LPS-induced protein oxidation and proteolysis in BV-2 microglial cells. IUBMB Life. 50, 331 335.
68. Moulédous L., Neasta J., Uttenweiler-Joseph S., Stella A., Matondo M., Corbani M., Monsarrat B. Meunier J. C. (2005) Long-term morphine treatment enhances proteasome-dependent degradation of G beta in human neuroblastoma SH-SY5Y cells: correlation with onset of adenylate cyclase sensitization. Mol. Pharmacol. 68, 467 476.
69. Mousa S. A., Shakibaei M., Sitte N., Schafer M. Stein C. (2004) Subcellular pathways of beta-endorphin synthesis, processing, and release from immunocytes in inflammatory pain. Endocrinology 145, 1331 1341.
70. Nakajima K., Tohyama Y., Kohsaka S. Kurihara T. (2001) Ability of rat microglia to uptake extracellular glutamate. Neurosci. Lett. 307, 171 174.
71. Nath A., Hauser K. F., Wojna V., Booze R. M., Maragos W., Prendergast M., Cass W. Turchan J. T. (2002) Molecular basis for interactions of HIV and drugs of abuse. J. Acquir. Immune Defic. Syndr. 31 (Suppl. 2 S62 S69.
72. Nelson P., Soma L. Lavi E. (2002) Microglia in diseases of the central nervous system. Ann. Med. 34, 491 500.
73. Nencioni A., Grunebach F., Patrone F., Ballestrero A. Brossart P. (2006) The proteasome and its inhibitors in immune regulation and immune disorders. Crit. Rev. Immunol. 26, 487 498.
74. Ocasio F. M., Jiang Y., House S. D. Chang S. L. (2004) Chronic morphine accelerates the progression of lipopolysaccharide-induced sepsis to septic shock. J. Neuroimmunol. 149, 90 100.
75. Ortiz-Lazareno P. C., Hernandez-Flores G., Dominguez-Rodriguez J. R., Lerma-Diaz J. M., Jave-Suarez L. F., Aguilar-Lemarroy A., Gomez-Contreras P. C., Scott-Algara D. Bravo-Cuellar A. (2008) MG132 proteasome inhibitor modulates proinflammatory cytokines production and expression of their receptors in U937 cells: involvement of nuclear factor-kappaB and activator protein-1. Immunology 124, 534 541.
76. Ovadia H., Magenheim Y., Behar O. Rosen H. (1996) Molecular characterization of immune derived proenkephalin mRNA and the involvement of the adrenergic system in its expression in rat lymphoid cells. J. Neuroimmunol. 68, 77 83.
77. Pawate S., Shen Q., Fan F. Bhat N. R. (2004) Redox regulation of glial inflammatory response to lipopolysaccharide and interferon-gamma. J. Neurosci. Res. 77, 540 551.
78. Peterson P. K., Sharp B. M., Gekker G., Portoghese P. S., Sannerud K. Balfour H. H. J. (1990) Morphine promotes the growth of HIV-1 in human peripheral blood mononuclear cell cocultures. AIDS 4, 869 873.
79. Peterson P. K., Gekker G., Hu S., Anderson W. R., Kravitz F., Portoghese P. S., Balfour H. H. J. Chao C. C. (1994) Morphine amplifies HIV-1 expression in chronically infected promonocytes cocultured with human brain cells. J. Neuroimmunol. 50, 167 175.
80. Peterson P. K., Molitor T. W. Chao C. C. (1998) The opioid-cytokine connection. J. Neuroimmunol. 83, 63 69.
81. Piani D., Spranger M., Frei K., Schaffner A. Fontana A. (1992) Macrophage-induced cytotoxicity of N-methyl-D-aspartate receptor positive neurons involves excitatory amino acids rather than reactive oxygen intermediates and cytokines. Eur. J. Immunol. 22, 2429 2436.
82. Polazzi E., Levi G. Minghetti L. (1999) Human HIV-1 Tat protein stimulates inducible nitric oxide synthase and nitric oxide production in microglial cultures. J. Neuropathol. Exp. Neurol. 58, 825 831.
83. Price T. O., Uras F., Banks W. A. Ercal N. (2006) A novel antioxidant N-acetylcysteine amide prevents gp120- and Tat-induced oxidative stress in brain endothelial cells. Exp. Neurol. 201, 193 202.
84. Przewlocki R., Hassan A. H., Lason W., Epplen C., Herz A. Stein C. (1992) Gene expression and localization of opioid peptides in immune cells of inflamed tissue: functional role in antinociception. Neuroscience 48, 491 500.
85. Qin L., Liu Y., Wang T., Wei S., Block M. L., Wilson B., Liu B. Hong J. S. (2004) NADPH oxidase mediates lipopolysaccharide-induced neurotoxicity and proinflammatory gene expression in activated microglia. J. Biol. Chem. 279, 1415 1421.
86. Quang-Cantagrel N. D., Wallace M. S., Ashar N. Mathews C. (2001) Long-term methadone treatment: effect on CD4+ lymphocyte counts and HIV-1 plasma RNA level in patients with HIV infection. Eur. J. Pain 5, 415 420.
87. Rambhia S., Mantione K. J., Stefano G. B. Cadet P. (2005) Morphine modulation of the ubiquitin-proteasome complex is neuroprotective. Med. Sci. Monit. 11, BR386 BR396.
88. Reid S., Cross R. Snow C. (1996) Combined Hoechst 33342 and merocyanine 540 staining to examine murine B cell cycle stage, viability and apoptosis. J. Immunol. Method 192, 43 54.
89. Remoli A. L., Marsili G., Perrotti E. et al. (2006) Intracellular HIV-1 Tat protein represses constitutive LMP2 transcription increasing proteasome activity by interfering with the binding of IRF-1 to STAT1. Biochem. J. 396, 371 380.
90. Risdahl J. M., Khanna K. V., Peterson P. K. Molitor T. W. (1998) Opiates and infection. J. Neuroimmunol. 83, 4 18.
91. Rojavin M., Szabo I., Bussiere J. L., Rogers T. J., Adler M. W. Eisenstein T. K. (1993) Morphine treatment in vitro or in vivo decreases phagocytic functions of murine macrophages. Life Sci. 53, 997 1006.
92. Roy S., Wang J., Kelschenbach J., Koodie L. Martin J. (2006) Modulation of immune function by morphine: implications for susceptibility to infection. J. Neuroimmune Pharmacol. 1, 77 89.
93. Ruzicka B. B., Fox C. A., Thompson R. C., Meng F., Watson S. J. Akil H. (1995) Primary astroglial cultures derived from several rat brain regions differentially express m, d and kappa opioid receptor mRNA. Mol. Brain Res. 34, 209 220.
94. Sappington R. M. Calkins D. J. (2006) Pressure-induced regulation of IL-6 in retinal glial cells: involvement of the ubiquitin/proteasome pathway and NFkappaB. Invest. Ophthalmol. Vis. Sci. 47, 3860 3869.
95. Sheng W. S., Hu S., Hegg C. C., Thayer S. A. Peterson P. K. (2000) Activation of human microglial cells by HIV-1 gp41 and Tat proteins. Clin. Immunol. 96, 243 251.
96. Smith M. A., Sayre L. M., Anderson V. E., Harris P. L., Beal M. F., Kowall N. Perry G. (1998) Cytochemical demonstration of oxidative damage in Alzheimer disease by immunochemical enhancement of the carbonyl reaction with 2,4-dinitrophenylhydrazine. J. Histochem. Cytochem. 46, 731 735.
97. Stiene-Martin A., Zhou R. Hauser K. F. (1998) Regional, developmental, and cell cycle-dependent differences in mu, delta, and kappa-opioid receptor expression among cultured mouse astrocytes. Glia 22, 249 259.
98. Streit W. J., Walter S. A. Pennell N. A. (1999) Reactive microgliosis. Prog. Neurobiol. 57, 563 581.
99. Streit W. J., Miller K. R., Lopes K. O. Njie E. (2008) Microglial degeneration in the aging brain - bad news for neurons? Front. Biosci. 13, 3423 3438.
100. Sun B., Tipton C. M. Bidlack J. M. (2006) The expression of prodynorphin gene is down-regulated by activation with lipopolysaccharide in U-937 macrophage cells. J. Neuroimmunol. 174, 52 62.
101. Takeuchi H., Wang J., Kawanokuchi J., Mitsuma N., Mizuno T. Suzumura A. (2006) Interferon-gamma induces microglial-activation-induced cell death: a hypothetical mechanism of relapse and remission in multiple sclerosis. Neurobiol. Dis. 22, 33 39.
102. Turchan-Cholewo J., Dimayuga F. O., Ding Q., Keller J. N., Hauser K. F., Knapp P. E. Bruce-Keller A. J. (2008) Cell-specific actions of HIV-Tat and morphine on opioid receptor expression in glia. J. Neurosci. Res. 86, 2100 2110.
103. Tyor W. R., Wesselingh W., Griffith S. W., McArther J. C. Griffen D. E. (1995) Unifying hypothesis of the pathogenesis of HIV-associated dementia complex, vacuolar myelopathy, and sensory neuropathy. J. AIDS Human Ret. 9, 379 388.
104. Ullrich O., Diestel A., Bechmann I., Homberg M., Grune T., Hass R. Nitsch R. (2001) Turnover of oxidatively damaged nuclear proteins in BV-2 microglial cells is linked to their activation state by poly-ADP-ribose polymerase. FASEB J. 15, 1460 1462.
105. UNAIDS (2006) 2006 Report on the Global AIDS Epidemic. United Nations, Geneva.
106. Walker J. S. (2003) Anti-inflammatory effects of opioids. Adv. Exp. Med. Biol. 521, 148 160.
107. Wang J., Barke R. A., Charboneau R. Roy S. (2005) Morphine impairs host innate immune response and increases susceptibility to Streptococcus pneumoniae lung infection. J. Immunol. 174, 426 434.
108. Wang X., Douglas S. D., Peng J. S., Zhou D. J., Wan Q. Ho W. Z. (2006) An in vitro model of morphine withdrawal manifests the enhancing effect on human immunodeficiency virus infection of human T lymphocytes through the induction of substance P. Am. J. Pathol. 169, 1663 1670.
109. Westendorp M. O., Shatrov V. A., Schulze-Osthoff K., Frank R., Kraft M., Los M., Krammer P. H., Droge W. Lehmann V. (1995) HIV-1 Tat potentiates TNF-induced NF-kappa B activation and cytotoxicity by altering the cellular redox state. EMBO J. 14, 546 554.
110. Yang L., Wang S., Sung B., Lim G. Mao J. (2008) Morphine induces ubiquitin-proteasome activity and glutamate transporter degradation. J. Biol. Chem. 283, 21703 21713.